Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a specialized operator at the GP level, sharing in the promote and accessing a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a seasoned operator to co-GP on lab space developments, leveraging their expertise to share in the promote.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level, focusing on those with a strong track record in navigating market fluctuations.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the San Diego life science market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests as the market seeks to recover from high vacancy rates.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a strong pipeline.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, focusing on projects that can capitalize on the current high vacancy rates.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a pipeline of projects.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level to capitalize on the high venture capital funding and address the idle lab space.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, leveraging their expertise to navigate the rising vacancy landscape.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of potential tenants.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, leveraging co-GP or JV equity to align interests and share in the promote.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, focusing on those with a strong pipeline despite current market headwinds.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator at the GP level, engaging in co-GP or JV equity arrangements to share in the promote.

Co-GP / Platform:A family office could deploy into the Houston life sciences market by backing a sponsor/operator focused on developing biopharmaceutical facilities, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of high-quality lab assets.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator through co-GP or JV equity to share in the promote and enterprise value.